Discover 10 success stories of the 5 Flemish universities by TTO Flanders on the FRIS research portal (EWI) with VUB research about self-healing robots and a one-stop-shop solution for photonics...
Herman Terryn is professor at the Faculty of Engineering of VUB with a chair in Surface Science and Engineering and part time professor in the group Corrosion and Electrochemical of Tu Delft. He was...
In the context of this project the VUB built the Circular Retrofit Lab as a demonstrator lab on its campus (Brussels), in which new and existing building solutions will be integrated that are...
In September 2019 VUB added a new spin-off to its portfolio, called Axiles Bionics. Later that month the company announced that it has successfully completed a €2.4M Series A financing round, led by...
Photonics is the science and technology of light. Light technology plays a key role in the social megatrends such as digitization, IoT, big data, artificial intelligence and autonomous transport...
Get to know Mimi Deprez We would like to introduce you to Mimi, a member of our European Research and Innovation Support (ERIS) team within VUB TechTransfer. With over 30 years of experience in...
Abscint, a VUB spin-off, has recently been granted a notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent application. The patent, titled ‘Radio-labelled...
Get to know Hugo Loosvelt Allow us to introduce Hugo, the IP, licensing, and spin-off manager at VUB TechTransfer. Hugo's expertise in intellectual property rights and licensing makes him a key...
Get to know Qing Cai Meet Qing, our Business Developer at VUB TechTransfer. She specializes in helping researchers turn their applied research into products or services, specifically in the Brussels...
Jan Steyaert, director of the VIB-VUB Center for Structural Biology and professor at Vrije Universiteit Brussel (VUB), is the first Belgian scientist to receive the prestigious Jacob and Louise...
Swave Photonics has announced that semiconductor industry veteran Mike Noonen takes the helm as CEO to lead metaverse innovator’s next stage of growth. Noonen joins Swave to expand the investment and...
mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers invest in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA to expand its expertise and capabilities...
VUB spin-off Precirix, the clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, discloses that they signed an agreement with Eckert & Ziegler for the supply...
Swave Photonics, an innovator in Holographic eXtended Reality (HXR) technology to bring the metaverse to life, announced a €7 million seed round. The investment will be used to fund the...
VUB spin-off Precirix , a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announces the closing of a €80M Series B financing round led by new...
Couples unable to get pregnant naturally often resort to In Vitro Fertilisation (IVF) to fulfil their desire to have children. To obtain mature eggs for IVF, women typically undergo ovarian...
Read the articles about the large-scale living lab Green Energy Park and the one-stop-shop for photonics in De Standaard. We teamed up with Maarten Messagie and Thierry Coosemans of the VUB research...
Together with VLIR and TTO Flanders we present a new brochure "From idea to impact" about how the 5 Flemish universities innovate for a better society and how they make a difference. This publication...
A new VUB spin-off named ABSCINT NV was established, based on technology developed by the joint research efforts of the teams of Prof. Dr. Tony Lahoutte and Prof. Dr. Jo Van Ginderachter at VUB and...
Visit the Youtube channel of MOBI , the Mobility, Logistics and Automotive Technology Research Centre of the VUB and watch videos about seminars, research pitches and more. Discover the lab during a...
Looking for an introduction about our services and the support we offer to the VUB research community? Interested in an overview of the funding opportunities in Flanders, Brussels and Europe? Or a...
NEW START-UP ANIMAB SECURES €3.4M SEED INVESTMENT TO IMPROVE HEALTH AND PERFORMANCE OF LIVESTOCK ANIMALS Animab, a venture spin-off from VIB, announces today that it has successfully concluded a €3...
Knowing what citizens and consumers really think of new measures, products or advertising is crucial for governments and businesses. But it is often difficult to find out. iCense, a new spin-off from...
Annual Report of the Vicerectorate Innovation & Industry Relations During times of crisis, as we are are experiencing now in 2020 with the pandemic COVID-19, multidisciplinary research and co-...
Jan Steyaert is a professor at the VUB and scientific director at VIB. He leads the Jan Steyaert Lab in Structural Biology . His passion lies in scientific research, but at the same time he has a...
Today access to high-quality research infrastructure is vital for providing research opportunities and the ability to create knowledge and technologies. Such infrastructure attracts top scientists...
If the number of covid-19 patients in Belgium continues to rise, there may be a shortage of artificial respirators. A team of engineers at Vrije Universiteit Brussel’s FabLab Brussels has therefore...
At the end of 2019, hbits was officially welcomed as a spin-off of VUB. As part of the Human and Social Sciences, hbits grew – under the daily management of researcher Joeri Minnen (left) and...
Humans and robots are increasingly working together. To make this collaboration as safe as possible for people and for the work they do, “soft robots” made of flexible and soft materials are becoming...
This new VUB spin-off, in collaboration with imec, developed a video game for children who stutter. In their associated ETRO-Lab they used software technology and speech recognition. They are...
The new VUB AI Experience Center is a space to experiment with AI and robotics and to produce technological solutions, and allows participants to strengthen their digital skills. It’s aimed at...
